• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Bioventus Inc Cl A (NQ: BVS )

    11.53 -0.25 (-2.12%)
    Streaming Delayed Price Updated: 1:09 PM EDT, Oct 3, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Headline News about Bioventus Inc Cl A

    < Previous 1 2 3 Next >
    Executives Buying W. P. Carey And 2 Other Stocks
    Via Benzinga
    BVS Stock Earnings: Bioventus Beats EPS, Beats Revenue for Q2 2024
    BVS stock results show that Bioventus beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
    Via InvestorPlace
    Yum China Posts Upbeat Earnings, Joins Clear Secure, TG Therapeutics, Bioventus And Other Big Stocks Moving Higher On Tuesday
    Via Benzinga
    3 Stocks Under $10 With Mammoth Growth Prospects
    Learn more about the growth stocks under $10 with progressive fundamentals in the healthcare and technology sectors. 
    Via InvestorPlace
    Why AppLovin Shares Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    A Preview Of Bioventus's Earnings
    Via Benzinga
    Earnings Preview: Bioventus
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
    Pre-market stock movers are a hot topic this morning and we've got traders covered with all of the news behind these movements on Thursday! 
    Via InvestorPlace
    Exact Sciences Reports Q1 Loss, Joins Beyond Meat, Duolingo And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
    Via Benzinga
    Nasdaq Moves Lower; Great Lakes Dredge & Dock Shares Surge Following Upbeat Earnings
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Intraday Session
    Via Benzinga
    Bioventus Earnings Preview
    Via Benzinga
    Recap: Bioventus Q1 Earnings
    Via Benzinga
    Earnings Preview: Bioventus
    Via Benzinga
    Why Beyond Shares Are Trading Lower By Over 20%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    BVS Stock Earnings: Bioventus Beats EPS, Beats Revenue for Q1 2024
    BVS stock results show that Bioventus beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
    Via InvestorPlace
    Blend Labs Reports Q4 Results, Joins Alta Equipment, Despegar.com And Other Big Stocks Moving Higher On Friday
    U.S. stocks were lower, with the Dow Jones index falling around 100 points on Friday. Shares of Blend Labs, Inc. (NASDAQ: BLND) rose sharply during Friday’s session after the company reported... 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Why Asana Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Shares of Asana, Inc. (NYSE: ASAN) fell sharply during Tuesday’s session following soft FY25 revenue guidance. 
    Via Benzinga
    Bioventus Reports Upbeat Earnings, Joins Ranpak, Beachbody And Other Big Stocks Moving Higher On Tuesday
    U.S. stocks were higher, with the Dow Jones index surging more than 200 points on Tuesday. 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga
    Earnings Scheduled For March 12, 2024
    Companies Reporting Before The Bell • Aurora Mobile (NASDAQ:JG) is likely to report earnings for its fourth quarter. 
    Via Benzinga
    MedTech Bioventus' Stabilization Sparks Analyst Confidence, Earns Upgrade And Price Target Boost
    Canaccord Genuity has upgraded Biomedical Devices and Services company Bioventus Inc (NASDAQ: BVS), highlighting greater insight into the progress of the turnaround and plans for future investment and... 
    Via Benzinga
    Bioventus And 3 Other Stocks Under $5 Insiders Are Buying
    The Dow Jones closed lower by 175 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in... 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    12 Health Care Stocks Moving In Thursday's Intraday Session
    Via Benzinga
    Over $1M Bet On Bioventus? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying
    The Dow Jones closed lower by over 200 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... 
    Via Benzinga
    Why Bluejay Diagnostics Shares Are Trading Lower By 12%; Here Are 20 Stocks Moving Premarket
    Gainers Visionary Education Technology Holdings Group Inc. (NASDAQ: VEDU) shares rose 85.8% to $0.7985 in pre-market trading. 
    Via Benzinga
    Barnwell Industries And 3 Other Stocks Under $3 Insiders Are Aggressively Buying
    The Dow Jones closed higher by over 300 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... 
    Via Benzinga
    $25M Bet On This Consumer Cyclical Stock? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying
    The Dow Jones closed lower by over 250 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... 
    Via Benzinga
    Over $2.5M Bet On This Healthcare Stock? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying
    The Dow Jones closed lower by over 200 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... 
    Via Benzinga
    Why Y-mAbs Therapeutics Shares Are Trading Higher By 50%? Here Are Other Stocks Moving In Friday's Mid-Day Session
    Gainers Y-mAbs Therapeutics, Inc (NASDAQ: YMAB) climbed 49.9% to $4.93 after the company posted a profit for the fourth quarter. 
    Via Benzinga
    < Previous 1 2 3 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.